(Yicai Global) Feb. 7 -- A unit under Tianjin Chase Sun Pharmaceutical Co. is able to sell its crude drugs in three foreign countries after obtaining certification in the US, Germany and Russia.

Crude drugs are raw products derived from plants and animals.

Hubei Enoray Biopharmaceutical Co. has received an establishment inspection report in America and the Good Manufacturing Practices certification in Germany and Russia, the parent company said in a statement today.

The drug administrations in the three countries prioritized different drugs in assessments, but all products checked were those containing anticoagulants heparin sodium or heparin calcium, the statement said.

The firm has submitted applications to sell the approved products in America, Russia and countries which accept the German GMP certificate.